Schedule 13D ownership disclosure

INTRA-CELLULAR THERAPIES INC

Security class unavailable · CUSIP: 46116X101

Event date: 2017-10-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-17-324890
Form type
SC 13D/A
Filer
ALAFI CAPITAL CO LLC
CIK
CIK 1216017
Filed
Oct 30, 2017
Reporting period
Oct 02, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub